arginine vasopressin has been researched along with Cardiovascular Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Szczepanska-Sadowska, E | 1 |
| Aikins, AO; Brock, C; Cunningham, JT; Farmer, GE; Nguyen, DH; Paundralingga, O; Shimoura, CG | 1 |
| Matyjaszek-Matuszek, B; Szmygin, H; Szydełko, J | 1 |
| Cudnoch-Jedrzejewska, A; Czarzasta, K; Szczepanska-Sadowska, E | 1 |
| Atsumi, W; Hirayama, A; Tachibana, E; Tani, S | 1 |
| Binder, L; Edelmann, F; Herrmann-Lingen, C; Meyer, T; Sadlonova, M; Wachter, R | 1 |
| Afsar, B; Cherney, DZI; Covic, A; Dincer, N; Johnson, RJ; Kanbay, M; Lanaspa, MA; Ortiz, A; Sag, AA; Sánchez-Lozada, LG; Yilmaz, S | 1 |
| Alkhalaf, A; Bakker, SJ; Bilo, HJ; Boertien, WE; Gansevoort, RT; Groenier, KH; Kleefstra, N; Navis, G; Riphagen, IJ; Struck, J; van Hateren, KJ | 1 |
| Cervenak, L; Csuka, D; Farkas, H; Jani, PK; Kajdácsi, E; Prohászka, Z; Varga, L | 1 |
| Guelinckx, I; Lemetais, G; Perrier, ET; Vecchio, M | 1 |
| Bardosono, S; Gandy, J; Guelinckx, I; Kavouras, SA; Martinez, H; Moreno, LA; Salas-Salvadó, J | 1 |
| Mueller, PJ | 1 |
| Morgenthaler, NG | 1 |
| Bankir, L; Bouby, N; Enhörning, S; Hedblad, B; Melander, O; Morgenthaler, NG; Nilsson, PM; Persson, M; Struck, J | 1 |
| Shoji, M; Yasujima, M | 1 |
| Barrett-Bergshoeff, MM; Brommer, EJ; Gevers Leuven, JA; Schouten, JA | 1 |
| Baver-Neff, BS; Cronenwett, JL; Grekin, RJ; Sheagren, JN | 1 |
7 review(s) available for arginine vasopressin and Cardiovascular Diseases
| Article | Year |
|---|---|
The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases.
Topics: Angiotensins; Arginine Vasopressin; Cardiovascular Diseases; Cardiovascular System; Cytokines; Heart Failure; Humans; Hypertension; Lung; Oxytocin; Vasopressins | 2022 |
Cardiovascular Neuroendocrinology: Emerging Role for Neurohypophyseal Hormones in Pathophysiology.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Volume; Cardiovascular Diseases; Cardiovascular System; Humans; Hypothalamo-Hypophyseal System; Natriuresis; Oxytocin; Receptors, Oxytocin; Receptors, Vasopressin; Sex Characteristics | 2021 |
Copeptin as a novel biomarker of cardiometabolic syndrome.
Topics: Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycopeptides; Humans; Metabolic Syndrome; Neurophysins; Predictive Value of Tests; Protein Precursors; Vasopressins | 2021 |
Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular Diseases; Humans; Receptors, Vasopressin; Renin-Angiotensin System; Water-Electrolyte Balance | 2018 |
Antidiuretic Hormone and Serum Osmolarity Physiology and Related Outcomes: What Is Old, What Is New, and What Is Unknown?
Topics: Animals; Arginine Vasopressin; Cardiovascular Diseases; Dehydration; Humans; Kidney Diseases; Osmolar Concentration; Water-Electrolyte Balance | 2019 |
Copeptin: a biomarker of cardiovascular and renal function.
Topics: Arginine Vasopressin; Biomarkers; Blood Volume; Cardiovascular Diseases; Cardiovascular System; Glycopeptides; Heart Failure; Humans; Kidney; Kidney Diseases; Myocardial Infarction; Prognosis; ROC Curve; Shock, Cardiogenic; Stroke; Vasopressins | 2010 |
[Recent progress in vasopressin research on cardiovascular diseases].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Cardiovascular Diseases; Humans; Platelet Aggregation; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Receptors, Vasopressin; Tolvaptan | 2007 |
10 other study(ies) available for arginine vasopressin and Cardiovascular Diseases
| Article | Year |
|---|---|
Combined Evaluation of the Plasma Arginine Vasopressin and Noradrenaline Levels May be a Useful Predictor of the Prognosis of Patients with Acute Decompensated Heart Failure.
Topics: Aged; Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Female; Heart Failure; Hospitalization; Humans; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment | 2018 |
Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study.
Topics: Aged; Anxiety; Anxiety Disorders; Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Female; Humans; Male; Middle Aged; Neurophysins; Prognosis; Protein Precursors; Risk Factors; Sex Factors; Tomography, X-Ray Computed; Vasopressins | 2019 |
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).
Topics: Aged; Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glycopeptides; Humans; Male; Middle Aged; Sex Factors | 2013 |
Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Topics: Adrenomedullin; Adult; Angioedemas, Hereditary; Arginine Vasopressin; Cardiovascular Diseases; Case-Control Studies; Complement C1 Inhibitor Protein; Disease Progression; Endothelin-1; Female; Hereditary Angioedema Types I and II; Humans; Male; Middle Aged; Risk Factors; Young Adult | 2016 |
Fluid Intake and Vasopressin: Connecting the Dots.
Topics: Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Drinking; Glycopeptides; Health Status; Humans; Hyperglycemia; Metabolic Syndrome; Models, Biological; Renal Insufficiency, Chronic; Risk Factors; Vasopressins; Water-Electrolyte Balance | 2016 |
Relevance of Assessment Methods for Fluid Intake.
Topics: Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Dehydration; Drinking; Female; Glomerular Filtration Rate; Glycopeptides; Health Status; Humans; Hyperglycemia; Male; Metabolic Syndrome; Models, Biological; Prognosis; Renal Insufficiency, Chronic; Risk Factors; Urine; Vasopressins; Water-Electrolyte Balance | 2016 |
Influence of sedentary versus physically active conditions on regulation of plasma renin activity and vasopressin.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular Diseases; Heart Rate; Male; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Risk Factors; Running | 2008 |
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
Topics: Age Distribution; Age of Onset; Aged; Aged, 80 and over; Albuminuria; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycopeptides; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Neoplasms; Obesity, Abdominal; Predictive Value of Tests; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Sweden; Time Factors | 2013 |
Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia.
Topics: Adult; Aged; Antigens; Arginine Vasopressin; Cardiovascular Diseases; Cholesterol; Chylomicrons; Deamino Arginine Vasopressin; Factor VIII; Female; Fibrinolysis; Humans; Hyperlipoproteinemias; Male; Middle Aged; Plasminogen Activators; Risk; Serum Globulins; Triglycerides | 1982 |
The role of endorphins and vasopressin in canine endotoxin shock.
Topics: Animals; Arginine Vasopressin; beta-Endorphin; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Dogs; Endorphins; Endotoxins; Escherichia coli; Female; Heart Rate; Hydrocortisone; Kinetics; Male; Naloxone; Shock, Septic | 1986 |